Literature DB >> 15665344

Treated threshold stage 3 versus spontaneously regressed subthreshold stage 3 retinopathy of prematurity: a study of motility, refractive, and anatomical outcomes at 6 months and 36 months.

J Sahni1, N V Subhedar, D Clark.   

Abstract

AIM: To compare the visual acuity (VA), spherical equivalent refractive error, motility, and anatomical outcomes in children with treated regressed threshold stage 3 retinopathy of prematurity (ROP) and those with spontaneously regressed subthreshold stage 3 ROP.
METHOD: 6 month and 3 year data collected from infants examined between 1989 and 1999 with regressed stage 3 ROP, with or without treatment were retrospectively reviewed.
RESULTS: 85 infants were included in this study. 40 eyes received cryotherapy, 81 eyes laser photocoagulation, and 34 eyes had spontaneously regressed subthreshold stage 3 ROP. Grating acuity score > or =2 cycles/degree (c/d) at 6 months was predictive of optotype acuity > or =6/9 in 69% of eyes and a score <2 c/d at 6 months was predictive of acuity < 6/9 in 88% of eyes. Eyes with subthreshold stage 3 ROP were twice as likely to have VA of 6/9 or better at 36 months than the treated eyes. The mean spherical equivalent refractive error at 36 months was -6.5 dioptres (D) (-21.5D to +1.38D) in cryotherapy treated eyes, -2.4D (-13D to +4D) in the laser group, and -0.22D (-9D to +2.25D) in the subthreshold group. Eyes within the treated groups were more myopic than the eyes within the spontaneously regressed group (p = 0.005). At 36 months, 42 out of the 85 infants (that is, 49%) had strabismus (44% in the cryotherapy group, 26% in the laser group, and 25% in the subthreshold group). There was a statistically significant association between the presence of strabismus and anisometropia (p = 0.016) and strabismus and intraventricular haemorrhage (IVH) (p = 0.005). There was a statistically significant difference in the incidence of strabismus between mild and moderate and severe grade IVH (p = 0.01). Eight out of 40 eyes in the cryotherapy group and six out of the 81 eyes in the laser group developed macular ectopia. None of the eyes in the spontaneously regressed group had macular dragging.
CONCLUSIONS: In this study, the grating acuity at 6 months was a good predictor of the 3 year optotype acuity in all groups. Eyes with spontaneously regressed subthreshold stage 3 ROP were associated with better vision at 3 years of age and a lesser degree of myopia compared to the treated groups. Strabismus developed predominantly in the treated groups and was frequently associated with neurological damage and/or anisometropia. The spontaneously regressed subthreshold stage 3 group had a better anatomical outcome compared to the groups in which the retinopathy regressed following treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15665344      PMCID: PMC1772499          DOI: 10.1136/bjo.2004.045815

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  39 in total

1.  Anterior segment abnormalities in cicatricial retinopathy of prematurity.

Authors:  H M Hittner; L M Rhodes; A R McPherson
Journal:  Ophthalmology       Date:  1979-05       Impact factor: 12.079

2.  Sequelae of arrested mild retinopathy of prematurity.

Authors:  D B Schaffer; G E Quinn; L Johnson
Journal:  Arch Ophthalmol       Date:  1984-03

3.  An international classification of retinopathy of prematurity. Prepared by an international committee.

Authors: 
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

4.  Visual outcomes after laser photocoagulation for threshold retinopathy of prematurity.

Authors:  B P Connolly; J A McNamara; C D Regillo; W Tasman; S Sharma
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

5.  Retinopathy of prematurity in practice. II: long-term results following treatment for threshold disease.

Authors:  L Gnanaraj; R Brennan; D G Cottrell
Journal:  Eye (Lond)       Date:  2003-03       Impact factor: 3.775

6.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  2003-12

7.  [Predictive value of teller Acuity Card Test (TACT) and comparison of recognition and grating acuities in premature children with and without residua of Retinopathy of Prematurity (ROP)].

Authors:  Alina A Zubcov; Beatrice M Rossillion; Borislav Kacer; Norbert Stärk; Rolf Schlösser; Karoline Vanselow
Journal:  Klin Monbl Augenheilkd       Date:  2002-10       Impact factor: 0.700

8.  Myopia in premature babies with and without retinopathy of prematurity.

Authors:  I Nissenkorn; Y Yassur; D Mashkowski; I Sherf; I Ben-Sira
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

9.  Ocular outcomes in low birth weight premature infants with intraventricular hemorrhage.

Authors:  Stephen P Christiansen; Katherine J Fray; Trey Spencer
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2002 May-Jun       Impact factor: 1.402

10.  Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity.

Authors:  Zsuzsa Récsán; Rita Vámos; György Salacz
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2003 Jul-Aug       Impact factor: 1.402

View more
  16 in total

Review 1.  The neurovascular retina in retinopathy of prematurity.

Authors:  Anne B Fulton; Ronald M Hansen; Anne Moskowitz; James D Akula
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

2.  Effect of Grade I and II intraventricular hemorrhage on visuocortical function in very low birth weight infants.

Authors:  Ashima Madan; Anthony M Norcia; Chuan Hou; Mark W Pettet; William V Good
Journal:  Seeing Perceiving       Date:  2012

3.  Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.

Authors:  Christopher K Hwang; G Baker Hubbard; Amy K Hutchinson; Scott R Lambert
Journal:  Ophthalmology       Date:  2015-02-14       Impact factor: 12.079

4.  Strabismus at Age 2 Years in Children Born Before 28 Weeks' Gestation: Antecedents and Correlates.

Authors:  Deborah K VanderVeen; Elizabeth N Allred; David K Wallace; Alan Leviton
Journal:  J Child Neurol       Date:  2015-09-08       Impact factor: 1.987

5.  Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial.

Authors:  Deborah K VanderVeen; Don L Bremer; Rae R Fellows; Robert J Hardy; Daniel E Neely; Earl A Palmer; David L Rogers; Betty Tung; William V Good
Journal:  J AAPOS       Date:  2011-12       Impact factor: 1.220

6.  Refractive and Visual Outcome after Laser-Treated Retinopathy of Prematurity in Western Romania.

Authors:  Florina Stoica; Corina Ladariu; Marie-Jeanne Koos; Alina Stanciu; Gabriela Olariu; Nicoleta Andreescu; Maria Puiu
Journal:  Maedica (Buchar)       Date:  2016-06

7.  Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.

Authors:  Yu-Bai Chou; An-Guor Wang; Hsin-Yu Yang; Kuan-Jung Chen; Chang-Sue Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-22       Impact factor: 3.117

8.  Long term visual outcomes in laser treated threshold retinopathy of prematurity in Central Saudi Arabia.

Authors:  Abdullah G Al-Otaibi; Sultan S Aldrees; Ahmed A Mousa
Journal:  Saudi J Ophthalmol       Date:  2012-06-07

9.  Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes.

Authors:  Y-H Chen; S-N Chen; R-I Lien; C-P Shih; A-N Chao; K-J Chen; Y-S Hwang; N-K Wang; Y-P Chen; K-H Lee; C-C Chuang; T-L Chen; C-C Lai; W-C Wu
Journal:  Eye (Lond)       Date:  2014-08-08       Impact factor: 3.775

10.  Structural and functional results of indirect diode laser treatment for retinopathy of prematurity from 1999 to 2003 in Kuwait.

Authors:  Vivek B Wani; Khalid Al Sabti; Niranjan Kumar; Seemant Raizada; Jamal Al Kandari; Mohammad Al Harbi; Rima Sawaan; Usha Rajaram; Niran Al-Naqeeb; Mumtaz Shukkur
Journal:  Clin Ophthalmol       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.